Back

Title
  • en Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy
Alternative
  • en Intestinal metastasis in melanoma
Creator
Accessrights open access
Rights
  • en This is the peer reviewed version of the following article: Miyazawa, H., Yanagi, T., Yamaguchi, Y., Imafuku, K., Kitamura, S., Hata, H., Uehara, J., Ichikawa, N., Ohno, Y., Yoshida, T., Homma, S., Kawamura, H., Taketomi, A. and Shimizu, H. (2017), Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy. J Dermatol, 44: 959-962., which has been published in final form at https://doi.org/10.1111/1346-8138.13825. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Subject
  • Other en fecal occult blood test
  • Other en intestinal metastasis
  • Other en malignant melanoma
  • Other en nivolumab
  • Other en weight loss
  • NDC 490
Description
  • Abstract en We report two cases of melanomas in patients who developed intestinal metastasis despite other metastatic sites responding to nivolumab and despite the patients having favorable findings such as vitiligo and normal lactate dehydrogenase. The first case is an 85-year-old man who had been administrated nivolumab for lung/cutaneous metastases. After 22 courses of nivolumab therapy, fever and anorexia had appeared and his bodyweight had decreased. An intussusception on the ileocecal valve was revealed by computed tomography, and emergency surgery revealed metastatic lesions on the colon. The second case is an 87-year-old woman treated with nivolumab for lymph node metastases. After 10 courses, laboratory tests had revealed anemia and positive fecal occult blood. Her bodyweight had decreased. Capsule endoscopy showed scattered tumors and clots, indicating metastases of melanoma. The frequency of symptomatic intestinal metastasis of melanoma is very low. Further, intestinal metastasis of melanoma is difficult to detect through routine examinations. Our cases suggest that fecal occult blood test and decreased bodyweight are indications of intestinal metastases.
Publisher en John Wiley & Sons
Date
    Issued2017-08
Language
  • eng
Resource Type journal article
Version Type AM
Identifier HDL http://hdl.handle.net/2115/71133
Relation
  • isVersionOf DOI https://doi.org/10.1111/1346-8138.13825
  • PMID 28295515
Journal
    • PISSN 0385-2407
      • en Journal of dermatology
      • Volume Number44 Issue Number8 Page Start959 Page End962
File
Oaidate 2023-07-26